Dr Emily Adams

I am a Reader and the diagnostic lead of the Centre for Drugs and Diagnostics (CDD) hosted by LSTM. We collaborate with a variety of SMEs and larger diagnostic companies to perform diagnostic development for infectious disease. We have projects ranging from detection of Anti-Microbial Resistance targets to the development of multiplex panel field tests for emerging infectious diseases and parasitology. We focus on the development of tests that can be used in community in low-resource settings where diagnostic results can initiate prompt and appropriate therapy.
During the COVID-19 pandemic I have been the PI for UK FIND (Foundation for Innovative New Diagnostics) evaluations, performing rolling evaluations of lateral flow antigen tests, with data used by FIND for WHO submissions.